Big decrease in marketing costs due to H and H doing most of the marketing.
Eureka report with Alan Koler interviewing Jo had assurances that there would be no need for further capital raising as cash flow positive is close and plenty of current funds in bank.
I prefer BDA due to them not trying to grow cannabis. Just developing range and sales.
- Forums
- ASX - By Stock
- Ann: 212% increase in medicinal cannabis product sales in FY2021
Big decrease in marketing costs due to H and H doing most of the...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BOD (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non-Executive Director
Simon Kidston
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online